SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥145.60+CN¥2.71 (+1.9%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.13% below the high.
Loading market information…
SHZ · 000908.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:12 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Hunan Jingfeng Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Hunan Jingfeng Pharmaceutical Co.,Ltd.’s forward annual dividend is CN¥0.01 per share, paid annual. The forward yield is 0.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hunan Jingfeng Pharmaceutical Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hunan Jingfeng Pharmaceutical Co.,Ltd., established in 2003 and headquartered in Shanghai, China, operates as a manufacturer and supplier of various pharmaceutical products, including chemical compounds and biological agents, within the Chinese market. A prominent offering from the company is its sodium hyaluronate injection, which finds extensive application in both orthopedic and surgical fields. Beyond this, their product range encompasses ophthalmology solutions and Active Pharmaceutical Ingredients (APIs). The firm also dedicates resources to the research and development of medications for anti-tumor, cancer, and cardiovascular conditions, alongside providing a selection of skincare products.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥145.60+CN¥2.71 (+1.9%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 16.13% below the high.
CN¥49.17+CN¥0.55 (+1.13%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.29% below the high.
HK$51.90+HK$1.25 (+2.47%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 35.89% below the high.
CN¥181.87+CN¥2.87 (+1.6%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 19.06% below the high.
HK$33.00-HK$0.08 (-0.24%)
Hansoh Pharmaceutical Group Company Limited’s quoted price sits in the lower half of its reported 52-week range, 25.37% below the high.
CN¥33.60+CN¥0.82 (+2.5%)
Bloomage BioTechnology Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 38.78% below the high.
CN¥34.09+CN¥0.39 (+1.16%)
Shenyang Xingqi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.29% below the high.
CN¥29.59+CN¥0.59 (+2.03%)
Shanghai Haohai Biological Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.04% below the high.
